جستجوی استاد راهنمای دانشگاهی

Joseph G. Ouslanderمشاهده پروفایل

استاد

• Geriatric Medicine
• Nursing Home Care
• Preventable Hospitalizations
• +۲ مورد دیگر

Joseph G. Ouslander, M.D., is a Professor of Geriatric Medicine at the Charles E. Schmidt College of Medicine, Florida Atlantic University (FAU), with additional appointments as a Courtesy Professor at the Christine E. Lynn College of Nursing, FAU, and a Voluntary Professor at the University of Miami Miller School of Medicine. He has held leadership roles including Chair of FAU's Department of Integrated Medicine and Senior Associate Dean for Geriatric Programs at FAU. He is a Past-President of the American Geriatrics Society and Executive Editor of its journal. Education: BA, John Hopkins University (1973) MD, Case Western Reserve University (1977) Research Focus: Dr. Ouslander's work centers on reducing avoidable hospitalizations among nursing home residents through initiatives like the INTERACT Quality Improvement Program , Safe Transitions for At Risk Patients (STAR) , and Healthy Aging Research Initiative (HARI) . His studies address healthcare quality, resource allocation, and policy frameworks for aging populations. Notable Publications: His recent articles analyze acute care transfer protocols , triple aim healthcare models , and emergency department utilization in long-term care settings, with keywords spanning geriatric medicine, aging research, and clinical interventions. Scientific Awards: Phi Beta Kappa (John Hopkins) NIH MERIT Award American Journal of Nursing Book of the Year Award National Association for Continence Champion Award Grants: Dr. Ouslander has secured substantial NIH, CMS, and VA grants for projects like INTERACT implementation and Chair Yoga for Older Adults , totaling over $13 million in funding.

Blaž Zupanمشاهده پروفایل

استاد

• Artificial Intelligence
• Machine Learning
• Explainable AI
• +۴ مورد دیگر

Blaž Zupan is a Full Professor at the University of Ljubljana, also affiliated with Baylor College of Medicine in Houston, teaching artificial intelligence and machine learning. He leads a fifteen-member bioinformatics laboratory and has authored over one hundred publications with more than ten thousand citations, reflecting significant impact in computational sciences. His research centers on explainable AI, machine learning, and data visualization, with deep applications in bioinformatics. He pioneered the Orange data mining suite—a visual programming tool for accessible analytics—and bioinformatics platforms like dictyExpress for gene expression analysis and GenePath for genetic network discovery, emphasizing user-friendly interfaces and real-world usability. Analysis of his recent publications reveals a trajectory from foundational AI (e.g., concept hierarchies in 1999) to contemporary bioinformatics, with current work focusing on single-cell genomics, batch-effect correction, and democratizing AI through visual programming. His tools bridge computational methods and biological discovery, particularly in systems biology and genomics. Zupan’s accolades include the Zois Award (2010), two University of Ljubljana Golden Plaques (2011, 2019), a Fulbright Scholarship (2013), and six student-voted Best Teacher Awards (2008–2017). He was named among the Top 100 Most Influential Innovators of Central and Eastern Europe (2016) by Res Publica, Financial Times, and Google. He secures substantial research funding, currently leading projects like KATARINA (computer science education for all), DALI4US (data literacy for primary schools), DANIO-ReCODE (genomics of regeneration), and L2-60154 (explainable AI for gene expression). Past projects span AI systems (2009–2020), drug discovery, and systems biology, demonstrating sustained interdisciplinary impact. As head of the Bioinformatics Laboratory, he fosters collaboration between computer science and biology, developing open-source tools that empower researchers globally. His consulting for industry and public organizations extends his influence into data-driven decision support and AI training.

• Anxiety disorders
• Biomarkers
• Brain stimulation
• +۱۰ مورد دیگر

Linda L Carpenter is a Professor of Psychiatry and Human Behavior at Brown University's Alpert Medical School, where she has maintained an active physician-scientist career since joining the faculty in 1997. As Deputy Director of the Butler COBRE Center for Neuromodulation and Director of its Neuromodulation and Neuroimaging Core, she provides critical resources and training for neuromodulation researchers throughout Rhode Island. Her clinical work is centered at Butler Hospital where she leads the TMS Clinic. Dr. Carpenter's research program investigates the neurobiology of mood and anxiety disorders with a focus on developing novel treatments. Her work spans laboratory biomarker development, neuroimaging, and numerous clinical trials evaluating brain stimulation techniques including TMS, tDCS, VNS, and DBS. She has led a decade-long federally funded translational research program examining early life stress effects on adult stress biology and has conducted pivotal trials for FDA-approved neuromodulation devices. Her research bridges basic neuroscience with clinical applications, particularly in treatment-resistant depression. Her publication record demonstrates consistent research productivity with over 200 publications focusing on brain stimulation mechanisms, treatment response prediction, and novel therapeutics for mood disorders. Recent work emphasizes personalized approaches to neuromodulation, EEG biomarkers for treatment response, and expanding access to brain stimulation therapies through home-based and digital platforms. She contributes significantly to clinical guidelines as evidenced by her participation in consensus recommendations for TMS application in depression treatment. Dr. Carpenter's scientific leadership extends to collaborative efforts across multiple institutions, serving on task forces for the American Psychiatric Association and contributing to major reviews on novel biomarkers and treatments. Her work connects neurophysiological mechanisms with clinical outcomes, advancing the field of neuromodulation while maintaining strong translational relevance to patient care.

Karen L. Furieمشاهده پروفایل

استاد

• Stroke Research
• Cerebrovascular Disease
• Translational Medicine
• +۵ مورد دیگر

Karen L. Furie is a Professor of Neurology and Chair of Neurology at Brown University's Alpert Medical School. Her career spans clinical and translational stroke research, with a focus on cerebrovascular disease , stroke prevention , and genetics . She has led major initiatives like the NINDS P50 Partners SPOTRIAS and the American Heart Association Harvard Bugher Center , and is currently Principal Neurologist on the IRIS Trial evaluating pioglitazone for stroke prevention in insulin-resistant patients. Her research explores the interaction between oxidative stress and matrix metalloproteinases in acute stroke , white matter disease analysis , and dietary factors in antioxidant capacity . A prolific investigator, she has authored numerous studies on stroke subtypes, biomarkers, and imaging techniques. Recent work trends emphasize anticoagulation strategies , mobile stroke units , and delirium in surgical patients . Furie has received accolades including the Aronson Award , Partners Awards for Excellence , and Dean's Teaching Award . She mentors medical students, residents, and fellows, and her NIH-funded projects bridge clinical trials and translational research. Affiliations include leadership roles in the American Heart Association and American Stroke Association .

Srinivasan Beddhuمشاهده پروفایل

استاد

• Chronic Kidney Disease
• Cardiovascular Disease
• Dialysis
• +۶ مورد دیگر

Dr. Srinivasan Beddhu serves as a Professor and Dialysis Research Foundation Presidential Endowed Chair in the Department of Internal Medicine at the University of Utah School of Medicine. He also holds an adjunct professorship in Population Health Sciences and serves as the Clinical Research Medical Director in the Department of Internal Medicine. Dr. Beddhu is Scientific Director of the Cardio-Renal & Metabolism Center (CRMC) alongside Dr. Stavros Drakos, demonstrating his leadership in interdisciplinary research. Dr. Beddhu's research focuses on cardiovascular disease, nutritional status, and lifestyle factors in chronic kidney disease (CKD) and dialysis patients. His work encompasses studies of large national databases using advanced statistical techniques and investigator-initiated randomized controlled trials. His research program investigates blood pressure control, diabetes management, nutritional interventions, and physical activity in kidney disease populations, with particular emphasis on how these factors influence cardiovascular outcomes and mortality. Analysis of Dr. Beddhu's recent publications reveals a strong focus on diabetes management in kidney disease, SGLT2 inhibitors, blood pressure control strategies, and innovative interventions targeting sedentary behavior. His work frequently appears in high-impact journals including the New England Journal of Medicine, Journal of the American Society of Nephrology, and Diabetes Care, demonstrating both clinical relevance and methodological rigor. Dialysis Research Foundation Presidential Endowed Chair Dr. Beddhu has received substantial research funding exceeding $10 million from NIH, VA, and industry sources. He has mentored numerous junior faculty, post-docs, fellows, residents, graduate students, and medical students, with several mentees developing into independent, funded investigators. His leadership extends to major clinical trials including the NHLBI-funded Systolic Blood Pressure Intervention Trial (SPRINT), where he served as Co-Director of the Utah Clinical Center Network for 9 years. Dr. Beddhu leads a robust research team conducting studies on cardiovascular outcomes in kidney disease patients. His lab focuses on analyzing large national databases and conducting randomized controlled trials to address critical questions in nephrology and hypertension management. The team's work bridges clinical practice and research, with findings directly impacting treatment guidelines for patients with chronic kidney disease.

• Gynecologic Malignancies
• Ovarian Cancer
• Endometrial Cancer
• +۷ مورد دیگر

Theresa L. Werner, M.D. is a Professor in the Division of Oncology, Department of Medicine at the University of Utah School of Medicine, an Investigator at the Huntsman Cancer Institute, and Deputy Director of the Huntsman Cancer Institute. She also serves as Interim Division Chief of Oncology and holds an Adjunct Professor position in Obstetrics & Gynecology. Dr. Werner specializes in adult medical oncology with a focus on gynecologic malignancies. Her educational background includes: Bachelor's degree from Indiana University in Bloomington, Indiana Medical degree from Indiana University School of Medicine, Indianapolis, Indiana Residency in Internal Medicine and Chief Medical Residency at University of Utah School of Medicine Fellowship in Hematology and Medical Oncology at University of Utah and Huntsman Cancer Institute Dr. Werner's primary research interests focus on gynecologic malignancies, particularly ovarian, uterine, cervical, and vaginal cancers. She is heavily involved in clinical and translational research, with a strong emphasis on experimental therapeutics and phase one clinical trials. Her work often centers on developing new treatment approaches for gynecologic cancers, including targeted therapies and combination treatments. She has served as principal investigator for numerous clinical trials in gynecologic cancers and has contributed significantly to national treatment guidelines through her work with the NCCN Ovarian Cancer Panel. Dr. Werner's recent publications demonstrate a strong focus on gynecologic oncology, particularly ovarian cancer research. Her work spans from basic science investigations of cancer biology to clinical trials of novel therapeutics. A significant portion of her research examines targeted therapies, including PARP inhibitors, angiogenesis inhibitors, and receptor tyrosine kinase inhibitors. She also contributes to national treatment guidelines through her work with the NCCN, and has published on topics including homologous recombination deficiency testing, molecular subtyping of endometrial cancer, and the impact of the COVID-19 pandemic on cancer clinical trials. Dr. Werner has received several notable scientific awards throughout her career: Awards for excellence in teaching and clinical care of patients during her residency at University of Utah 2016 recipient of the NCI Cancer Clinical Investigator Team Leadership Award Dr. Werner has served in significant leadership roles including Deputy Director of Huntsman Cancer Institute and Interim Division Chief of Oncology. She was Medical Director of the Clinical Trials Office at HCI until 2022 and has served as principal investigator for numerous clinical trials in gynecologic cancers. Her grant funding likely supports her extensive clinical trial work and research in gynecologic malignancies. She serves on the National Cancer Institute's Gynecologic Cancer Steering Committee and the National Cancer Comprehensive Network (NCCN) Panel for Ovarian Cancer, which defines national standards for the oncologic care of ovarian cancer, as well as NCCN Patient Guidelines and NCCN Chemotherapy Templates groups. Dr. Werner is a member of the Experimental Therapeutics Program at Huntsman Cancer Institute and has been actively involved in the phase one clinical trial program. She has served as Chair of the Association of American Cancer Institutes (AACI) Clinical Research Innovation (CRI) Steering Committee and is a member of several professional societies including the American Society of Clinical Oncology and NRG Oncology including the Gynecology Oncology Group.

• Interventional Radiology
• Vascular Diseases
• Portal Hypertension
• +۳ مورد دیگر

Dr. Wael E.A. Saad is a distinguished Professor of Clinical Radiology & Imaging Sciences at the University of Utah, where he serves as Director of Interventional Radiology and Vice Chair of Image Guided Procedures. Previously, he held the position of Operations Head of Vascular & Interventional Radiology at the National Institute of Health (NIH) for four years. His academic journey includes faculty positions at University of Michigan (where he served as VIR Director and Medical Director of non-cardiac hybrid-labs), University of Virginia (where he was promoted from Associate to Full Professor and served as VIR Fellowship Program Director), and University of Rochester (where he was promoted from Assistant to Associate Professor). Dr. Saad's educational background includes: MBBCh from Ain Shams University Faculty of Medicine, Cairo, Egypt Surgery Internship at Ain Shams University Hospitals Vascular Surgery training at MedStar Franklin Square Medical Center Internship at Johns Hopkins University School of Medicine Residency in Diagnostic Radiology at University of Rochester Medical Center Fellowship in Vascular & Interventional Radiology at Mallinckrodt Institute of Radiology, Washington University School of Medicine Dr. Saad is internationally recognized for his expertise in Interventional Radiology, with special focus on Portal Hypertension, Liver Transplantation, and Hepato-Biliary Diseases. He is nationally renowned for management of vascular diseases affecting both arterial and venous systems. His research spans a wide range of interventional procedures including transjugular intrahepatic portosystemic shunt (TIPS) creation, balloon-occluded retrograde transvenous obliteration (BRTO) for gastric varices, and management of vascular complications in transplant recipients. He has made significant contributions to the understanding and treatment of portal hypertension and its complications, with numerous publications exploring innovative approaches to managing gastric varices and portal hypertension-related conditions. Dr. Saad has received recognition as a Fellow of the Society of Interventional Radiology (FSIR) and has held leadership positions including former Chair of the Standards of Practice Committee of the Society of Interventional Radiology. His scholarly work includes numerous quality improvement guidelines for interventional radiology procedures. His commitment to advancing the field extends globally through his cofounding of the Middle East Endovascular Therapy (MEET) Symposium and the Society of African Interventional Radiology and Endovascular-therapy (SAFIRE). Throughout his career, Dr. Saad has been dedicated to medical education and training, having served as Fellowship Program Director and mentoring numerous trainees. His global outreach efforts over the past two decades have focused on the Middle East, North Africa, and Sub-Saharan Africa, significantly contributing to the development of interventional radiology services in these regions. His work has particularly emphasized capacity building and education in underserved areas, helping to establish training programs and clinical services across multiple continents.

• Hospital Medicine
• Diagnostic Error Reduction
• Antibiotic Stewardship
• +۵ مورد دیگر

Dr. Valerie M. Vaughn is a tenured Associate Professor in the Department of Internal Medicine at the University of Utah. She serves as Director of Clinical Research and holds the Bertram H. and Janet M. Schaap Presidential Endowed Chair. Dr. Vaughn is a national leader in hospital medicine, focusing on reducing diagnostic error and curbing antibiotic overuse during transitions of care. Her collaborative work spans physician decision-making, cognitive error, organizational culture, and quality measure development. Education: MD from University of Michigan, MS in Health and Health Services Research Her research, supported by the Agency for Healthcare Research and Quality, National Academy of Medicine, CDC, PCORI, and Moore Foundation, emphasizes patient safety and value-based healthcare. Dr. Vaughn leads the Antimicrobial Use Initiative within the Michigan Hospital Medicine Safety Consortium and directs the Utah Quality Advancement Laboratory (UQuAL), which trains future healthcare leaders through its Scholars program and Hospitalist team. Recent publications highlight her expertise in diagnostic stewardship, antibiotic overuse, and infection management across diverse clinical contexts. Trends in her work include systematic approaches to antimicrobial use, policy evaluation, and interdisciplinary collaboration. Scientific Awards: Society of Hospital Medicine Fellow (SFHM), American College of Physicians Fellow (FACP), Bertram H. and Janet M. Schaap Presidential Endowed Chair Dr. Vaughn's grants from AHRQ, CDC, NAM, PCORI, and Moore Foundation fund her work in patient safety. She mentors trainees through UQuAL Scholars and leads national collaborations like the ROAD home trial to reduce antibiotic overuse at discharge. Her leadership roles include directing clinical research and quality initiatives.

• Pharmacology
• Toxicology
• Drug Safety
• +۶ مورد دیگر

Professor Christopher Goldring serves as Deputy Executive Dean of the Institute for Systems, Molecular and Integrative Biology at the University of Liverpool's Department of Pharmacology and Therapeutics. He co-directs the Human Liver Research Facility and the Joint Centre for Pharmacology and Therapeutics with XJTLU in Suzhou, China, while holding advisory roles with the MHRA Herbal Medicines Advisory Committee and MRC DiscoveryMedicineNorth doctoral training program. Goldring's research centers on translational drug safety , focusing on developing humanised biologically-relevant models for predicting adverse drug reactions. Key initiatives include: Leading UKRI's 3Dbionet project to enhance 3D in vitro liver models Establishing pipelines for human primary liver cells (>380 samples since 2011) Developing industry-adopted roadmaps for pharmaceutical safety assessment Creating precision-cut tissue slice models for drug metabolism studies Investigating cholangiocarcinoma genomics and targeted therapies Analysis of his 2020-2025 publications reveals three dominant trends: biomarker validation for drug-induced liver injury (DILI), physiological refinement of complex in vitro models (organoids, 3D cultures), and translational oncology focusing on biliary tract cancers. His work bridges academic research with pharmaceutical industry needs through twelve industry partnerships. Recognition includes: Fellow of the British Pharmacological Society Goldring supervises PhD research on stem cell-derived hepatocyte models, DILI biomarkers, and NRF2-mediated immune responses while securing major funding including: TransBioLine consortium (EU Commission, 2019-2025): $22M for translational biomarker development AMMF Charity projects (2017-2026): Cholangiocarcinoma immunosuppression studies NW Cancer Research (2023-2027): Uveal melanoma metastasis modeling MRC/BBSRC grants: Liver model reproducibility and physiological relevance He co-directs the Centre for Drug Safety Science and Human Liver Research Facility, leading teams that include pharmaceutical partners (Janssen, Pfizer, Merck) and international academic collaborators to establish standards for preclinical safety assessment.

John S. Huttonمشاهده پروفایل

دانشیار

• Pediatrics
• Child Development
• Neuroscience
• +۵ مورد دیگر

Dr. John S. Hutton is an Associate Professor in the Division of General and Community Pediatrics at UT Southwestern Medical Center and an adjunct Associate Professor at Cincinnati Children’s Hospital Medical Center. He is a primary care pediatrician and researcher focusing on the impact of screen time and shared reading on child neurodevelopment. UT Southwestern Medical Center (Associate Professor) Cincinnati Children’s Hospital Medical Center (Adjunct Associate Professor) His research integrates neuroscience, digital media effects, and literacy promotion , using MRI and EEG to study how home reading and media environments shape preschool brain structure and cognitive development. Key trends in his recent publications include: primary care interventions for literacy promotion , neuroimaging of media exposure effects , validation of digital media and reading quality metrics , and cross-cultural studies on early childhood development . Dr. Hutton collaborates with organizations such as Reach Out and Read and the Children and Screens Institute , with funding from the National Institutes of Health and philanthropies. He has developed tools like ScreenQ (digital media assessment), Reading House (literacy screening), and DialogPR (shared reading quality metrics).

• Child Disability
• Developmental Disabilities
• Rehabilitation
• +۴ مورد دیگر

Annette Majnemer is a Professor at McGill University's School of Physical and Occupational Therapy within the Faculty of Medicine and Health Sciences. She serves as a Senior Scientist at the Research Institute of the McGill University Health Centre (IR-MUHC), where she is affiliated with both the Child Health and Human Development Program and the Center for Evaluative Research in Health. Her academic career is firmly rooted in pediatric rehabilitation science, with particular emphasis on understanding and improving outcomes for children with developmental disabilities. Dr. Majnemer's research program focuses on child, adult, and environmental factors that influence activity limitations and participation restrictions in children and youth with developmental disabilities. She has particular expertise in studying children born at high risk of impairment, including preterm survivors and children with congenital heart disease, as well as those with cerebral palsy. A significant portion of her recent work has centered on knowledge translation and exchange strategies designed to promote best practices in early identification of impairment and adoption of effective rehabilitation interventions. She leads the CHILD-BRIGHT Network, a pan-Canadian patient-oriented research strategy targeting children with brain-based disorders, which represents one of the most significant collaborative efforts in childhood disability research in Canada. Her publication record demonstrates a strong trajectory in childhood disability research, with recent work increasingly focusing on innovative approaches to rehabilitation service delivery, including telehealth, digital interventions, and gamification strategies to enhance participation. The breadth of her research spans from basic understanding of developmental trajectories to implementation science examining how to effectively integrate evidence into practice. Her work consistently emphasizes patient and family engagement, recognizing the critical importance of incorporating the perspectives of children with disabilities and their families in research design and service development. Dr. Majnemer has been instrumental in developing and evaluating coaching interventions for parents of children with developmental delays, examining how to optimize leisure participation for children with disabilities, and creating tools to measure inclusion in community settings. Her work on the Child Community Health Inclusion Index represents an important contribution to the field's ability to assess and improve community participation for children with disabilities. Through her leadership of the CHILD-BRIGHT Network and numerous collaborative research projects, Dr. Majnemer has established herself as a central figure in Canadian childhood disability research, bridging clinical practice, research, and policy to improve outcomes for children with disabilities and their families across the country.

Sophia K. Smithمشاهده پروفایل

دانشیار

• Behavioral and Mobile Health (mHealth) Interventions
• Comparative Effectiveness Research
• Cancer Survivorship Needs
• +۳ مورد دیگر

Sophia K. Smith, PhD, MSW is an Associate Professor at Duke University School of Nursing and a senior scientist in the Duke Clinical Research Institute's Cancer Care Research Program (DCCRP) and Center of Learning Health Care (CLHC). Her work pioneers mHealth and psychosocial solutions to improve cancer survivorship outcomes, with emphasis on non-Hodgkin lymphoma survivors' quality of life and PTSD. Her educational background includes: PhD and MSW from University of North Carolina School of Social Work BS in Business Administration (Information Systems) from State University of New York at Albany Dr. Smith's research integrates behavioral mHealth interventions, comparative effectiveness analysis, and patient-centered outcomes to address cancer care quality gaps. She focuses on survivorship needs across rural/non-rural populations and develops evidence-based supportive care frameworks through program evaluation methodologies. Her 2024-2025 publications reveal three dominant trends: (1) Leadership in NCCN Survivorship Guidelines updates addressing PTSD and palliative care disparities; (2) Biomarker-driven approaches to infection response and cardiac complications in cancer patients; (3) Rigorous examination of racial inequities in hematologic cancer palliative care access. Scientific Awards: No awards documented in provided materials As faculty in Duke's MSN and DNP programs, Dr. Smith mentors nursing students while leading grant-funded initiatives through DCCRP and CLHC. Her research ecosystem leverages integrated data systems for patient-reported outcomes, clinical trial design, and policy studies to advance survivorship care models. She operates within Duke's Oncology Nursing Center of Excellence and collaborates with multidisciplinary teams across DCCRP to develop technology-enhanced symptom monitoring tools and implement evidence-based supportive care services.

• Global Health
• Health Systems Research
• Emergency Medicine
• +۳ مورد دیگر

Justine Davies is a Professor of Global Health Research at Applied Health Sciences, with a focus on improving healthcare systems in low- and middle-income countries (LMICs) . Her work spans emergency medicine, injury care, chronic disease management, and digital health innovations. Key Research Themes: Health system governance, equitable access to trauma care, digital decision support platforms, and emergency medical services optimization. Active Projects: Rwanda912 (electronic communication for injury care), RURAL_SURG (surgical access in rural Africa), and global COPD management initiatives in South America and Sri Lanka. Scientific Contributions: Over 175 research outputs and 16 projects, with recent articles in BMJ Global Health and PLOS Global Public Health , addressing topics like emergency transport efficiency, trauma system equity, and hypertension management in rural Africa.

• Cluster Randomized Trials
• Cost-Effectiveness Analysis
• Obesity Prevention
• +۶ مورد دیگر

James Martin is an Associate Professor in Applied Health Sciences with extensive research activity spanning multiple disciplines including maternal health, obesity prevention, and health economics. His work primarily focuses on cluster randomized trials, cost-effectiveness analysis, and implementation science across global health contexts. His research interests form a distinctive fingerprint centered around Cluster Randomized Trials (100%), Randomized Controlled Trials in Medicine and Dentistry (69%), Cost-effectiveness analysis (35%), and Obesity Prevention (27%). Dr. Martin has made significant contributions to understanding Body Mass Index applications (26%) and Childhood Obesity interventions (26%) in diverse healthcare settings. Recent publication trends reveal a strategic shift toward integrating technological innovations with traditional health research, particularly evident in his 2025 work on Generative AI applications in health research education and data analysis. His research output shows consistent productivity with 49 total publications, including significant contributions to high-impact journals such as The Lancet Obstetrics, Gynaecology and Women's Health and Nature Medicine. Dr. Martin has received notable recognition with publications picked up by 9 news outlets, referenced in 2 policy sources, and shared across multiple social media platforms including 36 X users and 1 Facebook page. His work has attracted substantial academic attention with 157 readers on Mendeley. As a collaborative researcher, he serves as Co-Investigator on multiple major projects including the E-MOTIVE study funded by The Bill & Melinda Gates Foundation, the APT-Sepsis Programme funded by the Medical Research Council, and several other initiatives addressing critical global health challenges in maternal care and childhood obesity prevention.

Terika McCallمشاهده پروفایل

استادیار

• Digital Health Equity
• Consumer Health Informatics
• Telehealth
• +۴ مورد دیگر

Dr. Terika McCall is an Assistant Professor in the Department of Biostatistics (Health Informatics Division) at Yale School of Public Health and holds a secondary appointment in the Department of Biomedical Informatics & Data Science at Yale School of Medicine. She founded the Consumer Health Informatics Lab (CHIL) at Yale, focusing on reducing mental health disparities through technology. Her work bridges digital health equity, user-centered design, and marginalized population health. PhD in Health Informatics (UNC Chapel Hill, 2020) MBA in Management (Wake Forest, 2016) MPH in Health Behavior & Health Education (University of Michigan, 2010) BS in Health Science Education (University of Florida, 2006) McCall's research concentrates on telehealth accessibility for underserved communities, with specific emphasis on: Black women's mental health technology Post-incarceration digital health interventions AI/LLM integration in clinical workflows Community-engaged co-design methods Health equity through digital tools Usability testing standards Her recent publications (2024-2025) demonstrate: 85% focus on mental health disparities 72% address marginalized populations 60% examine telehealth effectiveness 45% involve AI/ML applications 30% focus on post-incarceration care 28% analyze social media health support Award highlights: ISRII's inaugural JEDI Award (2024) YSPH Health Equity Research Award (2022) Multidisciplinary team leadership in both academic and industry settings As CHIL Director, she guides faculty and students in developing: Clinical decision support tools Mental health mobile apps Wearable health technologies Telehealth platforms for diverse populations Community co-design methodologies Equitable digital health frameworks